#1//Andlauer HEALTHCARE GROUP Investor Presentation August 2023 A VITAL LINK IN HEALTHCARE#2Disclaimer Cautionary Note Regarding Forward-Looking Information //Andlauer HEALTHCARE GROUP This presentation contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. Forward-looking information may relate to our future financial outlook and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, plans and objectives. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "budget", "scheduled", "estimates", "outlook", "forecasts", "projection", "prospects", "strategy", "intends", "anticipates", "does not anticipate", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "will", "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances. This forward-looking information and other forward-looking information are based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions in respect of our ability to execute our growth strategies; our ability to retain key personnel; our ability to maintain and expand geographic scope; our ability to obtain financing on acceptable terms; interest rates; the impact of competition; the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards are material factors made in preparing forward-looking information and management's expectations. When relying on forward-looking statements to make decisions, we caution readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not the times at or by which such performance or results will be achieved. For further details on the forward- looking information included in this presentation, see "Cautionary Note Regarding Forward-Looking Information" in Andlauer Healthcare Group's Annual Information Form ("AIF) dated March 2, 2023 and the Company's most recent Management Discussion & Analysis ("MD&A"). A number of factors could cause actual results to differ, possibly materially, from the results discussed in the forward-looking statements. Prospective investors should carefully consider the risk factors described in the Company's AIF and most recent MD&A, before making an investment decision. The Company's AIF and most recent MD&A are filed on SEDAR and posted on the Company's website. Certain statements included in this presentation may be considered a "financial outlook" for purposes of applicable Canadian securities laws, and as such, the financial outlook may not be appropriate for purposes other than this presentation. All forward-looking information in this presentation is made as of the date hereof. Except as expressly required by applicable law, we assume no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. All of the forward-looking information contained in this presentation is expressly qualified by the foregoing cautionary statements. Non-IFRS Measures and Industry Metrics This presentation makes reference to non-IFRS measures, including "EBITDA" and "EBITDA Margin". These non-IFRS measures do not have standardized meanings prescribed by IFRS and therefore may not be comparable to similar measures presented by other companies. They are used to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Our management will also use non-IFRS measures and in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Please refer to the Company's most recent MD&A for further discussion of these non-IFRS financial measures and for a reconciliation to comparable IFRS measures, including net income and comprehensive income. Market and Industry Data This presentation includes market and industry data and forecasts that were obtained from third-party sources, industry publications and publicly available information as well as industry data prepared by management on the basis of its knowledge of the healthcare logistics and transportation services industry in which we will operate (including management's estimates and assumptions relating to the industry based on that knowledge). Management's knowledge of the healthcare logistics and transportation services industry has been developed through its experience and participation in the industry. Management believes that its industry data is accurate and that its estimates and assumptions are reasonable, but there can be no assurance as to the accuracy or completeness of this data. Third-party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there can be no assurances as to the accuracy or completeness of included information. Although management believes it to be reliable, we have not independently verified any of the data from management or third-party sources referred to in this presentation, or analyzed or verified the underlying studies or surveys relied upon or referred to by such sources, or ascertained the underlying economic assumptions relied upon by such sources. 2#3• Capital Market Profile IPO: December 2019 TSX: "AND" Subordinate Voting Shares ("SVS"): 20,082,3281 Multiple Voting Shares ("MVS"): 21,840,000 12 3 IPO issue price: $15.00 ³ Recent share price: $41.07 4 CIBC ANALYST COVERAGE Scotiabank • • • • SVS market capitalization: $825 million 4 Total market capitalization: $1.72 billion 4 52-week high/low: $55.97 / $40.90 4 //Andlauer HEALTHCARE GROUP Quarterly dividend: $0.09 / share ($0.36 annualized) 5 Dividend yield: ~ 0.8% 4 EIGHT CAPITAL NATIONAL BANK Capital Markets FINANCIAL MARKETS RBC STIFEL GMP TD Securities 1. As at June 30, 2023 4. August 4, 2023 2. 3. MVS are 100% owned by Andlauer Management Group December 11, 2019 5. Effective September 2023 (previously $0.08 per share) 3#4Who we are //Andlauer HEALTHCARE GROUP Leading and growing supply chain management company with a platform of customized logistics and specialized transportation solutions for the healthcare sector in Canada and the U.S. Four competitive strengths that span our platform and are designed for healthcare customers' needs: 1. Temperature management 2. Regulatory compliance and quality assurance 3. Supply chain visibility 4. Security FIVE DEDICATED HEALTHCARE PRODUCT LINES... + Logistics & Distribution Packaging Solutions Ground Transportation Air Freight Forwarding Dedicated and Last Mile Delivery ...FOCUSED ON A RANGE OF HEALTHCARE END MARKETS Pharmaceuticals Vaccines Biologics Blood Products H Nutraceuticals Health & Beauty Accessories Medical Devices Consumer Healthcare Animal Health Platform of companies: ACCURISTIX BOYLE Credo LSU MEDDS NOVA PACK Skelton AN ACCURISTIK COMPANY ADVANCING HEALTHCARE LOGISTICS Logise Support ATS Healthcare ATS Dedicated We deliver security. Truck Lines 4#5Acquisitions Since IPO Skelton Canada (Acquired March 2021): • Validated temperature control, state-of-the-art security systems and real-time monitoring / Leader in 2º C to 8º C and < -20º C shipments Skelton USA (Acquired 49% March 2021 / Acquired 100% Nov. 2021): Skelton expanded into the U.S. in 2017 due to customer demand and has grown rapidly Boyle Transportation (Acquired November 2021): • Based in Massachusetts / operates throughout the 48 contiguous U.S. states and to/from Canada Specialized transportation services to life sciences (~ 78% of revenue) and government/defense sectors (~ 22% of revenue) Logistics Support Unit (Acquired March 2022): Quebec-based third-party logistics provider offering specialty pharma, warehousing, distribution and order management services throughout Canada LSU //Andlauer HEALTHCARE GROUP Anclauer CRANCE CREDI Skelton TRAN BOYLE 5#6Investment Highlights //Andlauer HEALTHCARE GROUP 1 Established Provider of Essential Supply Chain Services to Leading Companies in the Healthcare Industry 2 Coast-to-Coast, Closed-Loop Network in Canada Supported by Specialized Infrastructure 3 Truckload Coverage of the Contiguous 48 U.S. States 4 Technology Supporting a Comprehensive Service Platform 5 Strong Financial Performance 6 Experienced Management Team Aligned with Shareholders and Strong Employee Culture 6#7Established Provider of Essential Supply Chain Services //Andlauer HEALTHCARE GROUP Description Contract Logistics & Distribution Client & customer integration, managed transportation, inventory management, secured warehousing, distribution & fulfillment Typically 3-5 master service agreements, including quality agreements Primary Clients Pharmaceutical Manufacturers Geography Canada-wide D G Packaging Solutions Co-packing/re-packing, assembly/custom work, design & supply, secondary Rx packaging Combination of contracts and project-based Pharmaceutical Manufacturers Canada-wide Ground Transportation Blend of owner-operated and employee drivers, pick-up and delivery, courier, LTL, preferred carrier Fee for service, often with quality agreements Third-Party Logistics Providers Wholesalers and Distributors Pharmaceutical Manufacturers Canada-wide/U.S. Air Freight Forwarding Guaranteed contracted space, airport to airport furtherance, dedicated staff Fee for service, often with quality agreements Third-Party Logistics Providers Wholesalers and Distributors Pharmaceutical Manufacturers Canada-wide Dedicated and Last Mile Delivery Last mile shipments to pharmacies and veterinarian clinics, pharmacy home-delivery service Typically 3-5 year contracts Wholesalers Distributors Pharmacies Canada-wide (Home delivery in Winnipeg only) % of Q2 2023 Revenue 1 Brands 23.0% 2.5% 60.5% 4.5% 9.5% AccuRISTIX Crēdo BOYLE APTANCING HEALTHCARE LOGISTICE ATS Healthcare We deliver security NOVA PACK MEDDS AN ACCRISTIE COMPANY Skelton Truck Lines ATS Healthcare ATS Dedicated 1. Prior to intersegment revenue eliminations 7#8Partner of Choice for Leading Companies in the Healthcare Industry Andlauer HEALTHCARE GROUP LONGSTANDING RELATIONSHIPS WITH MAJOR INDUSTRY PROVIDERS Strong client retention with an average client relationship across the top 20 clients by revenue of 15+ years Pharmaceutical Manufacturers Wholesalers and Distributors Third-Party Logistics Players BAYER BAYER SELECT CLIENT RELATIONSHIPS Boehringer Ingelheim MERCK 2Pfizer Roche teva Jean Coutu LONDON DRUGS MCKESSON SHOPPERS DRUG MART i Innomar Strategies AmerisourceBergen LYNDEN INTERNATIONAL LOGISTICS CO. ups KUEHNE+NAGEL 8#9Coast-to-coast, Closed-Loop Network Supported by Specialized Infrastructure //Andlauer HEALTHCARE GROUP TEMPERATURE MANAGEMENT Dedicated facilities Specialized vehicles Customized packaging 1. Square footage excludes cross-docks • NATIONAL INFRASTRUCTURE QUALITY ASSURANCE Highly regulated environment Significant GMP and GUI-0069 experience Long-standing relationships Qa A • Nationwide coverage with 31 leased facilities, and six third-party cross-docks More than 2.2 million sq. ft. of operating space¹ GMP-licensed and temperature mapped distribution facilities SUPPLY CHAIN VISIBILITY Proprietary IT systems • Reporting and regulatory compliance SECURITY Specialized management protocol for high value and controlled products • Purpose built monitoring system • Health Canada compliant vaults 6#10Truckload Coverage of the Contiguous 48 U.S. States //Andlauer HEALTHCARE GROUP Boyle Transportation and Skelton USA have of a combined fleet of 180 trucks and 300 trailers, providing: • • . • Validated temperature control GPS tracking security monitoring Transport of temperature-sensitive pharmaceuticals, biologics and vaccines Specialized management protocol for high value and controlled products Cross-border service (Canada / U.S.) Boyle generates approximately 20-25% of its revenue from U.S. defense sector BOYLE We deliver security. Skelton Truck Lines FTL services throughout the 48 contiguous United States Terminal facilities Acquisitions of Boyle and Skelton USA forms strategic platform for growth in U.S. market 10#11• Technology Supporting a Comprehensive Service Platform AHG's proprietary information systems enable end-to-end monitoring, offer complete supply chain visibility and are integrated with those of our clients and end customers FLEET-INTEGRATED HARDWARE A 28 190 000 -0 Edum FULL VISIBILITY REPORTING BOYLE Shipments Users List Columbus Cindreati anafor Nashville KENTUCKY //Andlauer HEALTHCARE GROUP WEST TENNESSEE Googlefen Filter Cha Tracking No. Charlotte CAROLINA Ne Current Bill of Lading/Reference Start Date MM/DD/WW End Date MM/DD/YYYY = All Pieces 2010/06/28 04:02 PM CHRSON Shipper Date Shipped Pieces 2010/02/04 Pickup Date 1221030 PM 22100 00 PM 52219000PM 522193 30 PM Tracking N 303500 Service Deer Drign Weight 213589 3012 Pharma-41 Pur-72 Pharms-41 Lakboume Ok Monete, NC Greg OH 505000 450 200AM 5000 Lackoume On 52319700AM 400 Dive Bach MS 523400PM 1 T Ref 82487329 PO 060580 Proof of Temperature - for Shipment: 13996074 Consignee Monitoring Time From 2010/02/06 01:48 2010/02/09 15:00 UTC Min Temperature 17.05 (C) Max Temperature 2304 (C) Avg Temperature 20.34 (C) Longest Total Time Out Od Oh Om Longest Time Out Longest Total Gap Time Longest Gap Time Od 0h 18m Od Chm 04.1h 47m Nate UTC is Coordinated Universal Time or Greenwich Mean Time 30- 20. POD POD Date/Time 2010/0209 07:00 POD Signature LLOYD TANAKA Delivered Ok Temperatura (Times are in UTC) 0207 0207 0207 0200 02:09 0209 22:43 03:43 00:45 13:40 18:40 2348 0441 02:45 14:40 19:40 00:45 05:40 10:43 0205 0206 0205 0206 0206 01:40 048 BOYLE Tracking #316555 Dep ZDJ ASB - 11#12Strong Financial Performance Revenue ($ millions) 23.7% CAGR 440 314 277 290 648 2018 2019 2020 2021 2022 //Andlauer HEALTHCARE GROUP EBITDA ($ millions)/ EBITDA Margin (%) 12 28.3% CAGR 119 174 79 71 27.1% 26.9% 64 25.1% 24.3% 23.2% 2018 2019 2020 2021 2022 1. EBITDA is defined as net income (loss) and comprehensive income (loss) for the period before: (i) income tax (recovery) expense; (ii) interest income; (iii) interest expense; and (iv) depreciation and amortization 2. Excluding the gain of $37.9 million on the step acquisition of 51% of Skelton USA Inc. in Q4 2021 12 12#13Experienced Management Team Aligned with Shareholders //Andlauer HEALTHCARE GROUP • 200+ combined years working in the logistics, transportation and healthcare industries CEO, through AMG, holds ~ 52% interest in AHG, combined with equity ownership by other management team members, ensures strong alignment with shareholders Michael Andlauer Chief Executive Officer Industry Experience Tenure 37 31 ATS Healthcare Prior Company Experience ACCURISTIX ***********ATIO L ASSOCIATED LOGISTICS Peter Bromley 27 4 CFO and Corporate Secretary ups LIVINGSTON pwc Wish you alw Stephen Barr 32 13 President, Transportation KPMG CALYX Concord Bob Brogan 37 President, Specialty Solutions 21 21 DAY ROSS CP CN Dean Berg, 28 19 ACCURISTIX SEVINCING HEALTHIANE LOGISTICE President, Logistics McKesson Logistics Solutions MSKESSON Canada CEVA LOGISTICS Ron Skelton 44 President, Skelton Companies March 2021 Skelton Truck Lines Andrew Boyle / Marc Boyle 31/31 Co-Presidents, Boyle Transportation November 2021 BOYLE J.P.Morgan We deliver security." McKinsey & Company 13 33#14Strong Employee Culture Strong employee culture has driven AHG forward as an industry leader in high-quality healthcare logistics and transportation services Boyle Transportation named the "Best Fleet to Drive For" in the U.S. and Canada (2020 & 2021) Skelton Truck Lines selected as a finalist for: Northbridge Insurance Transportation Safety Award (March 2021) and "Best Fleet to Drive For" in the U.S. and Canada (December 2020) ☆ Transparency Excellence Accountability //Andlauer HEALTHCARE GROUP BOYLE BEST Fleets We deliver security. TO DRIVE FOR Skelton Truck Lines AHG recognizes its people are its most important asset and promotes personnel from within to retain top talent TRANSPORTATION SAFETY AWARD 2021 FINALIST 14#15ULT Freeser MAXIMUM DOOR OPEN TIME NOT MORE THAN 3 MINUTES Thermo SCIENTIFIC NUMBER 1 Wait at least 60 minutes ofter opening and closing until next entry into freem or ensure temperature on door reeds below-68°C 76 SYSTEM OK /Andlauer HEALTHCARE GROUP Temperature Range-72 No High Than-84 To remove chart prese 3 only after new chart has been installed press by Q2 2023 Financial Review 15#16Q2 2023 Financial Review //Andlauer HEALTHCARE Year-over-year decline in revenue primarily reflects superior U.S. ground transportation rate premiums, higher revenue related to COVID-19 vaccines and ancillary products, higher fuel surcharges and unusually high air freight forwarding volumes in Q2 2022. GROUP ~0.8% of revenue generated from distribution of COVID vaccines and ancillary products, compared to ~ 2.6% in Q2 2022. Three months ended Three months ended (In 000's, except percentages) Revenue Logistics and Distribution Packaging Healthcare Logistics Segment Ground Transportation June 30, 2023 June 30, 2022 Change $ 39,438 $ 41,845 (5.8)% 4,236 6,164 (31.3)% 43,674 48,009 (9.0)% 103,451 106,332 (2.7)% Air Freight Forwarding 7,678 11,534 (33.4)% Dedicated and Last Mile Delivery 16,339 17,117 (4.5)% Less: Intersegment Eliminations (13,785) (13,590) 1.4% Specialized Transportation Segment Total Revenue 113,683 121,393 (6.4)% $ 157,357 $ 169,402 (7.1)% 16#171. Q2 2023 Financial Review Total Revenue ($ millions) Operating Income ($ millions) Net Income ($ millions) 169.4 30.2 -7.1% 157.4 -25.1% 22.6 Q2 2022 Q2 2023 Q2 2022 21.0 -25.1% 15.7 Q2 2023 Q2 2022 Q2 2023 //Andlauer HEALTHCARE GROUP EBITDA ($millions) and Margin (%) 1 46.3 -14.7% 39.5 27.3% 25.1% Q2 2022 Q2 2023 Q2 2022 EPS: $0.49 / share (diluted) Q2 2023 EPS: $0.37 / share (diluted) EBITDA is defined as net income (loss) and comprehensive income (loss) for the period before: (i) income tax (recovery) expense; (ii) interest income; (iii) interest expense; and (iv) depreciation and amortization 17#18YTD 2023 Financial Review //Andlauer HEALTHCARE • The year-over-year decline in net income and EBITDA is primarily attributable to reduced contributions from Boyle Transportation and Skelton USA, lower outbound volume for Accuristix and lower air freight forwarding revenue in Q2 2023, and the decline in revenue related to COVID-19 vaccines and ancillary products. Six months ended GROUP (In 000s, except percentages and per share amounts) Six months ended June 30, 2023 June 30, 2022 Variance Revenue Logistics and Distribution Packaging $ 79,961 $ 75,090 6.5% 9,746 11,922 (18.3)% Healthcare Logistics Segment 89,707 87,012 3.1% Ground Transportation 211,711 203,826 3.9% Air Freight Forwarding 15,220 19,130 (20.4)% Dedicated and Last Mile Delivery 33,470 32,562 2.8% Less: Intersegment Eliminations (27,977) (24,777) 12.9% Specialized Transportation Segment 232,424 230,741 0.7% Total Revenue 322,131 317,753 1.4% Operating expenses (275,846) (263,434) 4.7% Operating income 46,285 54,319 (14.8)% Net Income 32,244 37,456 (13.9)% Foreign currency translation adjustment (5,239) Total comprehensive income $ 27,005 EPS (diluted) $ 0.76 $ EBITDA EBITDA Margin $ 80,009 24.8% $ 85,713 27.0% N/A (34.2)% $ (0.12) (6.7)% (220 bps) 3,608 $ 41,064 0.88 18#19Strong Balance Sheet (in $000s) As at June 30, 2023 As at Dec. 31, 2022 Cash and cash equivalents $ 84,265 $ 65,855 Total Assets 709,185 712,460 Debt Revolving credit facility Term facility Lease liabilities Total Debt Total Liabilities Total Equity Net Debt 1 / LTM EBITDA 2 49,691 49,557 106,352 113,729 156,043 163,286 247,457 271,468 461,728 440,992 0.43x 0.56x //Andlauer HEALTHCARE GROUP 1. Net Debt defined as total debt less cash and cash equivalents 2. LTM EBITDA defined as net income (loss) and comprehensive income (loss) for the trailing 12-month period before: (i) income tax (recovery) expense; (ii) interest income; (iii) interest expense; and (iv) depreciation and amortization 19#20CLINICAL TRIALS ACCURISTIX /Andlauer HEALTHCARE GROUP Growth Opportunities 20 20#21育 Attractive Industry Fundamentals //Andlauer HEALTHCARE We are well-positioned at the forefront of several accelerating healthcare market trends North American outsourced healthcare logistics and transportation market growth outpacing GDP growth GROUP TRENDS DRIVING INDUSTRY GROWTH Aging Population and Increased Life Expectancy Increasing Number of Healthcare and Adjacent Products with Unique Logistics Needs Increasing Industry Regulation Increasing Demand for Distributed and Ancillary Healthcare Logistics Services NORTH AMERICAN OUTSOURCED HEALTHCARE LOGISTICS AND TRANSPORTATION MARKET (US$BN)(1) 2020 2025 CAGR: 6.1% 2015-2020 CAGR: 5.7% 39.9 29.7 31.3 33.0 37.3 35.0 22.5 23.5 24.5 25.6 26.8 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F (1) Source: Healthcare Logistics Market in North America 2019-2023/2021-2025 reports by Technavio 34.3 25.3 2.5 3.4 1.9 2.2 United States Canada Mexico 2020 2025F 21#22Organic Growth: Strengthening our Clients' Connection to our Growing Platform //Andlauer HEALTHCARE GROUP Continued client education and increased regulatory oversight drives increased spending on AHG services EXPANDING DEDICATED DELIVERY BUSINESS Leverage our existing nation-wide network of facilities, dedicated equipment and client relationships Expand on regional relationships with existing clients in new geographies and secure new client contracts • ACCURISTIX CAPACITY GROWTH AHG has a history of generating growth from new and existing clients Adding incremental square footage to serve new clients, while adding excess capacity through capital-efficient leases ACCURISTIX ADVANCING WEALTHCARE LOGISTICE 598,000 sq. ft. Brampton expansion (+51,000 sq. ft.) Brampton expansion (+222,000 sq. ft.) DEVELOPING NEW SERVICES We are continuously developing new offerings that complement our existing logistics services offering H RA & QA Consulting Destruction 校 MEDDS ATS Dedicated 2013 2015 2016 2019 2020 800 Clinical Trial Logistics Vaughan expansion (+365,000 sq. ft.) Calgary expansion (+23,000 sq. ft.) HT Medical Devices 22#23Acquisition Growth: Expanding and Strengthening our Platform Leveraging our core capabilities across a broader array of services to enhance our platform STRATEGIC APPROACH TO M&A Increasing scale by completing complementary tuck-in acquisitions • //Andlauer HEALTHCARE GROUP Accelerating expansion in growing verticals and gaining expertise in new verticals and geographies Dedicated & Last Mile Delivery Packaging Solutions Quality Assurance Consulting Clinical Trials Destruction Geographical Expansion Ground Transportation 8880) 8888 Primary Logistics & Packaging Customs Brokerage International Freight Forwarding Distribution 23#24ATS Healthcare /Andlauer HEALTHCARE GROUP Appendix 24#25A Highly Regulated Environment Regulation and security requirements are increasing in both Canada and abroad AHG'S KEY COMPANY COMPLIANCE STATUTES, REGULATIONS AND GUIDELINES • Health Canada's Good Manufacturing Practices Guide for Drug Products (GUI-0001) • Health Canada's Guidance on Drug Establishment Licenses and Associated Fees (GUI-0002) • Health Canada's Guidelines for Environmental Control of Drugs During Storage and Transportation (GUI-0069) • //Andlauer HEALTHCARE GROUP Health Canada's Guidance Document on the Import Requirements for Health Products Under the Food and Drugs Act and its Regulations (GUI-0084) • Health Canada's Guidelines for Active Pharmaceutical Ingredients (GUI-0104) . Health Canada's Guidance Documents for Medical Devices ⚫ Health Canada's Guidance Documents for Natural and Non-Prescription Health Products • • Food and Drugs Act and its regulations, including the Food and Drug Regulations and Natural Health Product Regulations Cannabis Act and its regulations . • Controlled Drugs and Substances Act and its regulations, including the Precursor Control Regulations and the Narcotic Control Regulations The United States Pharmacopeia (USP) chapter <1079> Good Storage and Distribution Practices for Drug Products for U.S. distribution Health Canada Santé Canada FDA EUROPEAN MEDICINES AGENCY SCIENCE MEDICINES HEALTH 25 25#26Governance //Andlauer HEALTHCARE GROUP Directors Rona Ambrose 123 Lead Director Michael Andlauer Peter Jelley Chair Principal Occupation Deputy Chair, TD Securities CEO of Andlauer Healthcare Group. Founder, President and CEO of Andlauer Management Group Inc. Founder, Bulldog Capital Partners Inc. President and CEO of Bulldog Capital Partners Inc. President and CEO of Trout River Capital Ltd. Cameron Joyce 1 President and CEO of Accuristix from 2009 to 2015. Chair of the Board of Directors of Accuristix from 2015 to 2019. Joseph Schlett 123 Evelyn Sutherland 12* 3 Thomas Wellner 13* Independent director with more than four decades of public accounting experience, including over 35 years with SB Partners LLP CFO of Staples Canada ULC President and CEO of Revera Inc. 1 Independent director / 2 Member of Compensation, Nominating & Governance Committee / 3 Member of the Audit Committee /* Denotes Committee Chair 26